Monod J, Wyman J and Changeux J-P (1965) On the nature of allosteric transitions:
A plausible model. J Mol Biol 12:88 –118.
Parker EM and Ross EM (1991) Truncation of the extended carboxyl-terminal
domain increases the expression and regulatory activity of the avian β-adrenergic
receptor. J Biol Chem 266:9987–9996.
Parma J, Duprez L, Van Sande J, Cochaux P, Gervy C, Mockel J, Dumont J and
Vassart G (1993) Somatic mutations in the thyrotropin receptor gene cause hy- perfunctioning thyroid adenoma. Nature (London) 365:649 – 651.
Pei G, Samama P, Lohse M, Wang M, Codina J and Lefkowitz RJ (1994) A constitutively active mutant beta 2-adrenergic receptor is constitutively desensitized
and phosphorylated. Proc Natl Acad Sci USA 91:2699 –2702.
Ramsay G, Evan GI and Bishop JM (1984) The protein encoded by the human
proto-oncogene c-myc. Proc Natl Acad Sci USA 81:7742–7746.
Samama P, Cotecchia S, Costa T and Lefkowitz RJ (1993) A mutation-induced
activated state of the β2-adrenergic receptor. Extending the ternary complex
model. J Biol Chem 268:4625– 4635.
Schall TJ, Lewis M, Koller KJ, Lee A, Rice GC, Wong GH, Gatanaga T, Granger GA,
Lentz R, Raab H, Kohr WJ and Goeddel DV (1990) Molecular cloning and expression of a receptor for human tumor necrosis factor. Cell 61:361–370.
Spiegel AM, Weinstein LS and Shenker A (1993) Abnormalities in G protein-coupled
signal transduction pathways in human disease. J Clin Invest 92:1119 –1125.
